Abstract

Through whole-genome sequencing analysis, we identified non-Leishmania parasites isolated from a man with a fatal visceral leishmaniasis–like illness in Brazil. The parasites infected mice and reproduced the patient’s clinical manifestations. Molecular epidemiologic studies are needed to ascertain whether a new infectious disease is emerging that can be confused with leishmaniasis.

Highlights

  • Through whole-genome sequencing analysis, we identified non-Leishmania parasites isolated from a man with a fatal visceral leishmaniasis–like illness in Brazil

  • Dermal lesions known as post–kalaazar dermal leishmaniasis (PKDL) have rarely been reported in Brazil [13], and the clinical aspect of the disseminated papular skin lesions on this patient differed from the clinical presentation of PKDL

  • Non-Leishmania parasites isolated from 2 patients with visceral leishmaniasis–like illness used for whole-genome sequencing, Brazil*

Read more

Summary

Introduction

Through whole-genome sequencing analysis, we identified non-Leishmania parasites isolated from a man with a fatal visceral leishmaniasis–like illness in Brazil. The Study During 2011–2012, we characterized 2 parasite strains, LVH60 and LVH60a, isolated from an HIV-negative man when he was years old and years old (Table; Appendix, https:// wwwnc.cdc.gov/EID/article/25/11/18-1548-App1.pdf). Non-Leishmania parasites isolated from 2 patients with visceral leishmaniasis–like illness used for whole-genome sequencing, Brazil*

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.